Meeting Report: First International ISHAGE Symposium on Minimal Residual Cancerстатья из журнала
Аннотация: This conference was held on June 23–25, 1996, at the Kunstlerhaus, Munich, Germany, and was sponsored by the International Society for Hematotherapy and Graft Engineering, as well as AMGEN, Glaxo-Wellcome, Baxter, Becton Dickinson, Bristol-Myers-Squibb, Dynal, Essex Pharma, Lilly, Sandoz, BIS Laboratories, Boehringer Mannheim, CellPro, Centocor, Hoffmann LaRoche AG, Micromet/Labor fur Molekulare Onkologie, and Stem Cell Technologies, Inc. The conference was organized and cochaired by Drs. Klaus Pantel, Gert Riethmuller (Institute for Immunology, University of Munich, Munich, Germany), and Thomas J. Moss (Children's Hospital Los Angeles, University of Southern California, Los Angeles, CA). Invited participants were R.C. Coombes (Charing Cross Hospital Medical School, London, United Kingdom), I. Diel (Uni Frauenklinik, Heidelberg, Germany), D. Dilloo (Department of Hematology/Oncology, St. Jude Medical Center, Memphis, TN), B. Dorken (Berlin, Germany), O. Fodstad (Norwegian Radium Hospital, Oslo, Norway), S. Fox (University of Oxford, Oxford, United Kingdom), W. Franke (German Cancer Research Center, Heidelberg, Germany), I. Funke (Chir. Klinik Klinikum Grosshadern, Munich, Germany), J. Gribben (Dana Farber Cancer Institute, Harvard Medical School, Boston, MA), I.R. Hart, St. Thomas Hospital, London, United Kingdom), J. Johnson (Institute for Immunology, University of Munich, Munich, Germany), U. Keilholz, (Med. Klinik u. Poliklinik V, Heidelberg, Germany), M. Kneba (Department of Hematology/Oncology, Gottingen, Germany), G. Kvalheim (Department of Medical Oncology and Radiotherapy, Montebello, Oslo, Norway), R. Mertelsmann (Department of Medical Hematology, University of Freiburg, Freiburg, Germany), A. Mitchell (Denver University, Denver, CO), M. Neumaier (Institut fur Klinische Chemie, Hamburg, Germany), R. Oberneder (Institute for Immunology, University of Munich, Munich, Germany), A. Ross (CellPro, Bothell, WA), D. Schendel (Institute for Immunology, University of Munich, Munich, Germany), J.G. Sharp (University of Nebraska, Omaha, NE), G. Schlimok (Zentralklinikum, Augsburg, Germany), R.C. Seeger (Children's Hospital Los Angeles, University of Southern California, Los Angeles, CA), and L. Bik To (Institute of Medicine and Veterinary Science, Adelaide, Australia).
Год издания: 1996
Авторы: Klaus Pantel, Thomas J. Moss
Издательство: Mary Ann Liebert, Inc.
Источник: Journal of Hematotherapy
Ключевые слова: Nanoplatforms for cancer theranostics
Другие ссылки: Journal of Hematotherapy (HTML)
PubMed (HTML)
PubMed (HTML)
Открытый доступ: closed
Том: 5
Выпуск: 5
Страницы: 511–517